The 2025 Annual Congress of the European Association for Cancer Research (EACR 2025), held from June 16–19 in Lisbon, welcomed more than 4,000 participants from around the world to explore the latest advancements in basic, preclinical, and translational cancer research. Euro-BioImaging was proud to contribute to this vibrant scientific forum, engaging with researchers and industry partners to highlight our imaging services and deepen our ties with the cancer biology community.
Euro-BioImaging was represented at the exhibition by Daniela Aviles, Erika Cerutti, and Alessandra Viale, who hosted a booth at the heart of the exhibition hall. Surrounded by leading microscopy and imaging companies—including ZEISS, Nikon, ThermoFisher, Hamamatsu, and our newest Euro-BioImaging Industry Board (EBIB) member, Proteintech. The team had exceptional visibility and numerous opportunities to connect with academic researchers and commercial partners alike.
Spotlight on Spatial Biology and Advanced Imaging
A key theme throughout the congress was the rapid rise of spatial biology in cancer research. Cutting-edge imaging of complex 2D and 3D in vitro models, such as organoids and spheroids, was prominently featured in both scientific presentations and exhibitor showcases. Technologies enabling spatial omics and integrated imaging workflows attracted significant interest, reflecting an increasing demand for advanced imaging infrastructure and expertise.
Euro-BioImaging Nodes are ideally positioned to meet these evolving needs. Techniques such as spatial transcriptomics and multiplex imaging are readily accessible through our UK Node, Flanders BioImaging Node, NMI Sweden Node, France BioImaging Node, and the Advanced Light and Electron Microscopy Node in Prague.
Engaging the Community and Promoting Access
In addition to showcasing imaging technologies, the Euro-BioImaging team emphasized the importance of open access to research infrastructure, particularly through projects such as CanSERV. Conversations with researchers and reviewers underscored the value of collaborative, cross-border science supported by shared resources and services.
Scientific sessions like “Mechanisms of Metastasis” highlighted a diverse range of imaging techniques, including confocal, light-sheet, and super-resolution microscopy. Meanwhile, the EMBO Symposium on Advanced In Vitro Models showcased innovative work using oblique plane microscopy to monitor spheroid dynamics—further illustrating the sophistication and imaging demands of today’s cancer models.
Connecting with Portuguese Imaging Facilities
While in Lisbon, the Euro-BioImaging team also visited local imaging facilities that are part of the Portuguese Euro-BioImaging Node. These meetings served to strengthen national collaborations, enhance understanding of the regional imaging landscape, and foster long-term engagement with local users. (Read more: on Portuguese BIN visit and PPBI visit).
Euro-BioImaging’s presence at EACR 2025 reaffirmed our dedication to empowering the cancer research community through open access to world-class imaging technologies and expertise. We are grateful to all the researchers, collaborators, and industry partners who connected with us in Lisbon—and we look forward to continued scientific exchange, collaboration, and innovation in the months and years to come.
More news from Euro-BioImaging
